Ashford Capital Management Inc Spectrum Pharmaceuticals Inc Transaction History

Ashford Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 15, 2019	SELL	$7.36 - $11.26 $1.05 Million - $1.61 Million	-142,737 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$9.08 - $11.84 $1.36 Million - $1.77 Million	-149,392 Reduced 51.14%	142,737 $1.53 Million
Q4 2018 Feb 15, 2019	SELL	$6.39 - $16.99 $1.57 Million - $4.17 Million	-245,515 Reduced 45.66%	292,129 $2.56 Million
Q3 2018 Nov 15, 2018	BUY	$16.52 - $24.82 $1.85 Million - $2.78 Million	111,942 Added 26.3%	537,644 $9.03 Million
Q2 2018 Aug 15, 2018	SELL	$14.31 - $21.75 $1.47 Million - $2.24 Million	-103,013 Reduced 19.48%	425,702 $8.92 Million
Q1 2018 May 15, 2018	BUY	$16.09 - $23.07 $2.67 Million - $3.83 Million	166,100 Added 45.81%	528,715 $8.51 Million
Q4 2017 Feb 15, 2018	BUY	$13.36 - $20.73 $4.84 Million - $7.52 Million	362,615	362,615 $6.87 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Ashford Capital Management Inc with notifications on news.